Texas A&M University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Texas A&M University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9301
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Texas A&M University (TAMU) is a research based university that provide educational and research services. The university offers undergraduate, graduate and professional courses to its students. It consists of various colleges and departments such as College of Agriculture and Life Sciences, College of Architecture, Mays Business School, Baylor College of Dentistry, College of Education and Human Development, engineering students testing a robotic device, Dwight Look College of Engineering, College of Geosciences and College of Veterinary Medicine and Biomedical Sciences, among others. TAMU also offers education in the field of law, liberal arts, medicine, public health and science, among others. The university provides undergraduate and graduate research programs. It operates in the US, Qatar, Mexico and Costa Rica. TAMU is headquartered in College Station, Texas, the US.

Texas A&M University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Texas A&M University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Texas A&M University, Medical Devices Deals, 2012 to YTD 2018 9
Texas A&M University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Texas A&M University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Texas A&M University and Greffex Sign Research Agreement 11
Texas A&M University Enters into Agreement with iBio 12
Licensing Agreements 13
Celltex Therapeutics Enters into Licensing Agreement with Texas A&M Institute for Regenerative Medicine 13
Xoma Enters into Licensing Agreement with Texas A&M University System 14
Texas A&M University – Key Competitors 15
Texas A&M University – Key Employees 16
Texas A&M University – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
Apr 18, 2018: National Academies’ Gulf Research Program Awards Over $340,000 to Assist Scientific Research Impacted by Hurricanes Harvey and Irma 18
Mar 05, 2018: Texas A&M Chemists Use Technology to Decode Language of Lipid-Protein Interaction 20
Feb 26, 2018: CPRIT awards more than $2.6 million to Texas A&M 23
Jan 10, 2018: Texas A&M Research shows Biological Clocks Could Improve Brain Cancer Treatmen 24
Dec 27, 2017: Technical University of Munich: Double strike against tuberculosis 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Texas A&M University, Pharmaceuticals & Healthcare, Key Facts 2
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Texas A&M University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Texas A&M University, Deals By Therapy Area, 2012 to YTD 2018 8
Texas A&M University, Medical Devices Deals, 2012 to YTD 2018 9
Texas A&M University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Texas A&M University and Greffex Sign Research Agreement 11
Texas A&M University Enters into Agreement with iBio 12
Celltex Therapeutics Enters into Licensing Agreement with Texas A&M Institute for Regenerative Medicine 13
Xoma Enters into Licensing Agreement with Texas A&M University System 14
Texas A&M University, Key Competitors 15
Texas A&M University, Key Employees 16
Texas A&M University, Subsidiaries 17

List of Figures
Texas A&M University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Texas A&M University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Texas A&M University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Texas A&M University, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Texas A&M University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cincinnati Financial Corp:企業の戦略・SWOT・財務情報
    Cincinnati Financial Corp - Strategy, SWOT and Corporate Finance Report Summary Cincinnati Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Second Military Medical University-医療機器分野:企業M&A・提携分析
    Summary Second Military Medical University (SMMU), subsidiary of Logistic Support Department of the Central Military Commission, formerly known as Medical College of the East China Military Commanding Region is an educational service provider that provides training, and research services. The univer …
  • bioMerieux Inc-医療機器分野:企業M&A・提携分析
    Summary bioMerieux Inc (bioMerieux), a subsidiary of Institut Merieux SA is a provider of diagnostic solutions. The company offers its products for clinical solutions which include blood culture, cancer diagnostics, cardiovascular disease, cardiovascular pathology, clinical laboratories, companion d …
  • Fisher & Paykel Appliances Holdings Limited:企業の戦略的SWOT分析
    Fisher & Paykel Appliances Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Can-Fite BioPharma Ltd (CANF)-製薬・医療分野:企業M&A・提携分析
    Summary Can-Fite BioPharma Ltd (Can-Fite) is a biopharmaceutical company that offers pharmaceutical discovery and clinical development services. The company's pipeline product portfolio includes CF101, CF102 and CF602. It develops its products by utilizing its platform technology based on the Gi pro …
  • Oil & Gas Development Co Ltd (OGDC):石油・ガス:M&Aディール及び事業提携情報
    Summary Oil & Gas Development Co Ltd (OGDCL) is an integrated upstream oil and gas company. It explores, develops and produces oil and gas from its assets in the provinces of Punjab, Sindh, Balochistan, and Kyber Pakhtoon Khawa (KPK) in Pakistan. OGDCL owns interests in operated and non-operated exp …
  • Nationwide Building Society:企業のM&A・事業提携・投資動向
    Nationwide Building Society - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nationwide Building Society Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Grasim Industries Ltd (GRASIM):企業の財務・戦略的SWOT分析
    Grasim Industries Ltd (GRASIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Redx Pharma Plc (REDX):企業の財務・戦略的SWOT分析
    Summary Redx Pharma Plc (Redx Pharma), formerly Redx Pharma Ltd is a drug discovery and development company that develops early stage and small molecule therapeutics. The company’s pipeline products include inhibitors for oncology and anti-infectives for treatment of diseases that include influenza …
  • GL Pharm Tech Corp (204840):製薬・医療:M&Aディール及び事業提携情報
    Summary GL Pharm Tech Corp (GL Pharm) is a pharmaceutical company. The company offers drug formulations and delivery technologies for generic marketed drug. It provides incrementally modified drugs, generic drugs, and G-SOREN Tab. GL Pharm provides generic drugs such as olmesartan, atorvastatin, ler …
  • Salem Media Group, Inc. (SALM):企業の財務・戦略的SWOT分析
    Salem Media Group, Inc. (SALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Shanghai Electric Power Co Ltd (600021):企業の財務・戦略的SWOT分析
    Summary Shanghai Electric Power Co., Ltd. (Shanghai Electric Power), a subsidiary of State Power Investment Corporation is an electric energy company that generates and supplies electricity and thermal power. The company generates electricity from coal-fired plants, gas-fired plants, IGCC, gas power …
  • Infratil Ltd (IFT):電力:M&Aディール及び事業提携情報
    Summary Infratil Limited (Infratil) is involved in providing energy, transportation and infrastructure services. The company operates through trustpower, Australian energy, direct connect, Perth energy, Tilt Renewables, Wellington Airport, NZ bus, snapper, infratil property, Metlifecare, RetireAustr …
  • Celltrion Healthcare Co Ltd (091990):製薬・医療:M&Aディール及び事業提携情報
    Summary Celltrion Healthcare Co Ltd (Celltrion) is engaged in distributing, marketing and selling of biosimilar and biological medicines. Its products include Remsima and Truxima. Remsima is a biosimilar monoclonal antibody medication used for autoimmune diseases, including Crohn's disease (CD), ulc …
  • Hospitality Properties Trust:企業のM&A・事業提携・投資動向
    Hospitality Properties Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hospitality Properties Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • B2W – Companhia Global Do Varejo
    B2W - Companhia Global Do Varejo - Strategy, SWOT and Corporate Finance Report Summary B2W - Companhia Global Do Varejo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Cargolux Airlines International S.A.:企業の戦略・SWOT・財務情報
    Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report Summary Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Novo Nordisk AS (NOVO B)-医療機器分野:企業M&A・提携分析
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • Monex Group, Inc.:企業の戦略・SWOT・財務情報
    Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • California Cryobank-製薬・医療分野:企業M&A・提携分析
    Summary California Cryobank (CCB) is a healthcare service provider that offers reproductive, stem cell and donor selection services. The center offers services such as donor semen, pricing, donor information subscriptions, graduate donors, donor information, consultation services, genetic services, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆